Assessment of pexelizumab in acute myocardial infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Armstrong, PW; Adams, PX; Hamm, CW; O'Neill, WW; Vahanian, AS; Granger, CB; Holmes, DR; Todaro, TG; Van de Werf, F

Published Date

  • November 28, 2006

Published In

Volume / Issue

  • 114 / 22

Start / End Page

  • 2425 - 2425

International Standard Serial Number (ISSN)

  • 0009-7322